• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

从健康组织到癌症的进展过程中致癌突变的积累。

Accumulation of Oncogenic Mutations During Progression from Healthy Tissue to Cancer.

机构信息

Department of Applied Mathematics, University of Washington, Lewis Hall 201, Box 353925, Seattle, WA, 98195, USA.

Herbold Computational Biology Program, Fred Hutchinson Cancer Center, 1241 Eastlake Ave E, Seattle, WA, 98102, USA.

出版信息

Bull Math Biol. 2024 Oct 29;86(12):142. doi: 10.1007/s11538-024-01372-3.

DOI:10.1007/s11538-024-01372-3
PMID:39472320
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11522190/
Abstract

Cancers are typically fueled by sequential accumulation of driver mutations in a previously healthy cell. Some of these mutations, such as inactivation of the first copy of a tumor suppressor gene, can be neutral, and some, like those resulting in activation of oncogenes, may provide cells with a selective growth advantage. We study a multi-type branching process that starts with healthy tissue in homeostasis and models accumulation of neutral and advantageous mutations on the way to cancer. We provide results regarding the sizes of premalignant populations and the waiting times to the first cell with a particular combination of mutations, including the waiting time to malignancy. Finally, we apply our results to two specific biological settings: initiation of colorectal cancer and age incidence of chronic myeloid leukemia. Our model allows for any order of neutral and advantageous mutations and can be applied to other evolutionary settings.

摘要

癌症通常是由健康细胞中驱动突变的顺序积累引起的。这些突变中的一些,如肿瘤抑制基因的第一个拷贝失活,可能是中性的,而另一些,如导致癌基因激活的突变,可能为细胞提供选择性生长优势。我们研究了一种多类型分支过程,该过程从稳态中的健康组织开始,并对中性和有利突变的积累进行建模,直到癌症发生。我们提供了关于前癌种群大小和到达具有特定突变组合的第一个细胞的等待时间的结果,包括恶变的等待时间。最后,我们将我们的结果应用于两种特定的生物学环境:结直肠癌的起始和慢性髓性白血病的年龄发病率。我们的模型允许中性和有利突变的任何顺序,并可应用于其他进化环境。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7cc1/11522190/c9f31de39e86/11538_2024_1372_Fig9_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7cc1/11522190/0aa1344e6b04/11538_2024_1372_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7cc1/11522190/41378e30c16e/11538_2024_1372_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7cc1/11522190/b45ad5998dce/11538_2024_1372_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7cc1/11522190/5a15eb120a4b/11538_2024_1372_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7cc1/11522190/644feaf9a707/11538_2024_1372_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7cc1/11522190/9859f0e48f75/11538_2024_1372_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7cc1/11522190/0eb594fe95b6/11538_2024_1372_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7cc1/11522190/3c8674d0f750/11538_2024_1372_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7cc1/11522190/c9f31de39e86/11538_2024_1372_Fig9_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7cc1/11522190/0aa1344e6b04/11538_2024_1372_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7cc1/11522190/41378e30c16e/11538_2024_1372_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7cc1/11522190/b45ad5998dce/11538_2024_1372_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7cc1/11522190/5a15eb120a4b/11538_2024_1372_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7cc1/11522190/644feaf9a707/11538_2024_1372_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7cc1/11522190/9859f0e48f75/11538_2024_1372_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7cc1/11522190/0eb594fe95b6/11538_2024_1372_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7cc1/11522190/3c8674d0f750/11538_2024_1372_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7cc1/11522190/c9f31de39e86/11538_2024_1372_Fig9_HTML.jpg

相似文献

1
Accumulation of Oncogenic Mutations During Progression from Healthy Tissue to Cancer.从健康组织到癌症的进展过程中致癌突变的积累。
Bull Math Biol. 2024 Oct 29;86(12):142. doi: 10.1007/s11538-024-01372-3.
2
Spatial Moran models, II: cancer initiation in spatially structured tissue.空间莫兰模型,II:空间结构组织中的癌症起始
J Math Biol. 2016 Apr;72(5):1369-400. doi: 10.1007/s00285-015-0912-1. Epub 2015 Jul 1.
3
Genetic models of human cancer as a multistep process. Paradigm models of colorectal cancer, breast cancer, and chronic myelogenous and acute lymphoblastic leukaemia.作为多步骤过程的人类癌症遗传模型。结直肠癌、乳腺癌、慢性粒细胞白血病和急性淋巴细胞白血病的范例模型。
J Exp Clin Cancer Res. 2005 Dec;24(4):505-14.
4
Spatial Measures of Genetic Heterogeneity During Carcinogenesis.致癌过程中遗传异质性的空间测量
Bull Math Biol. 2017 Feb;79(2):237-276. doi: 10.1007/s11538-016-0234-5. Epub 2016 Nov 30.
5
Accumulation of driver and passenger mutations during tumor progression.在肿瘤进展过程中积累的驱动突变和乘客突变。
Proc Natl Acad Sci U S A. 2010 Oct 26;107(43):18545-50. doi: 10.1073/pnas.1010978107. Epub 2010 Sep 27.
6
Revisiting the tumorigenesis timeline with a data-driven generative model.基于数据驱动的生成模型重探肿瘤发生时间线。
Proc Natl Acad Sci U S A. 2020 Jan 14;117(2):857-864. doi: 10.1073/pnas.1914589117. Epub 2019 Dec 27.
7
Mathematical model of colorectal cancer initiation.结直肠癌发生的数学模型。
Proc Natl Acad Sci U S A. 2020 Aug 25;117(34):20681-20688. doi: 10.1073/pnas.2003771117. Epub 2020 Aug 11.
8
Tissue-Predisposition to Cancer Driver Mutations.组织对癌症驱动突变的易感性。
Cells. 2024 Jan 5;13(2):106. doi: 10.3390/cells13020106.
9
A causal Bayesian network model of disease progression mechanisms in chronic myeloid leukemia.慢性髓性白血病疾病进展机制的因果贝叶斯网络模型
J Theor Biol. 2017 Nov 21;433:94-105. doi: 10.1016/j.jtbi.2017.08.023. Epub 2017 Sep 1.
10
Molecular biology of colorectal cancer.结直肠癌的分子生物学
Curr Probl Cancer. 1997 Sep-Oct;21(5):233-300. doi: 10.1016/s0147-0272(97)80003-7.

引用本文的文献

1
Bayesian inference of fitness landscapes via tree-structured branching processes.通过树状分支过程对适应度景观进行贝叶斯推断。
Bioinformatics. 2025 Jul 1;41(Supplement_1):i160-i169. doi: 10.1093/bioinformatics/btaf193.

本文引用的文献

1
Sequential mutations in exponentially growing populations.指数增长群体中的序列突变。
PLoS Comput Biol. 2023 Jul 10;19(7):e1011289. doi: 10.1371/journal.pcbi.1011289. eCollection 2023 Jul.
2
Waiting times in a branching process model of colorectal cancer initiation.结直肠癌发生的分支过程模型中的等待时间。
Theor Popul Biol. 2023 Jun;151:44-63. doi: 10.1016/j.tpb.2023.04.001. Epub 2023 Apr 24.
3
Clonal dynamics of haematopoiesis across the human lifespan.人类生命全程中的造血克隆动力学。
Nature. 2022 Jun;606(7913):343-350. doi: 10.1038/s41586-022-04786-y. Epub 2022 Jun 1.
4
Aspirin's effect on kinetic parameters of cells contributes to its role in reducing incidence of advanced colorectal adenomas, shown by a multiscale computational study.阿司匹林对细胞动力学参数的影响有助于其降低晚期结直肠腺瘤发生率的作用,这一作用通过多尺度计算研究得到证实。
Elife. 2022 Apr 13;11:e71953. doi: 10.7554/eLife.71953.
5
Mathematical model of colorectal cancer initiation.结直肠癌发生的数学模型。
Proc Natl Acad Sci U S A. 2020 Aug 25;117(34):20681-20688. doi: 10.1073/pnas.2003771117. Epub 2020 Aug 11.
6
Cancer recurrence times from a branching process model.从分支过程模型看癌症复发次数。
PLoS Comput Biol. 2019 Nov 21;15(11):e1007423. doi: 10.1371/journal.pcbi.1007423. eCollection 2019 Nov.
7
Competing evolutionary paths in growing populations with applications to multidrug resistance.在具有多药耐药性应用的增长群体中竞争的进化途径。
PLoS Comput Biol. 2019 Apr 15;15(4):e1006866. doi: 10.1371/journal.pcbi.1006866. eCollection 2019 Apr.
8
Population dynamics of normal human blood inferred from somatic mutations.从体细胞突变推断正常人体血液的种群动态。
Nature. 2018 Sep;561(7724):473-478. doi: 10.1038/s41586-018-0497-0. Epub 2018 Sep 5.
9
Fixation and Spread of Somatic Mutations in Adult Human Colonic Epithelium.成人结肠上皮体细胞突变的固定和扩散。
Cell Stem Cell. 2018 Jun 1;22(6):909-918.e8. doi: 10.1016/j.stem.2018.04.020. Epub 2018 May 17.
10
Only three driver gene mutations are required for the development of lung and colorectal cancers.肺癌和结直肠癌的发生仅需要三种驱动基因突变。
Proc Natl Acad Sci U S A. 2015 Jan 6;112(1):118-23. doi: 10.1073/pnas.1421839112. Epub 2014 Dec 22.